Susana Puig
Head of the Dermatology ServiceResearch group
- Melanoma: imaging, genetics and immunology Group leader (R4)
About me
Dr. Puig is the leader of the research group at IDIBAPS 'Melanoma: Imaging, Genetics, and Immunology', the head of the Dermatology Department at Hospital Clínic de Barcelona, and a full professor at the University of Barcelona. She is also a group leader at CIBERER and a member of the board of several scientific societies. She obtained her medical degree from the University of Barcelona and specialized in Dermatology in 1992, earning her doctoral degree in 2000. She has been involved in over 30 competitive research projects and more than 50 clinical trials, leading to the publication of over 500 scientific articles and the supervision of nearly 40 doctoral theses and final master's projects.
Featured publications
-
Optimizing treatment approaches for patients with cutaneous melanoma by integrating clinical and pathologic features with the 31-gene expression profile test
Authors:Reference: Journal Of The American Academy Of Dermatology 2022. -
Synchronous primary cutaneous melanomas: a descriptive study of their clinical features, histology, genetic background of the patients and clinical outcomes
Authors:Reference: Journal Of The European Academy Of Dermatology And Venereology 2022. -
Common genetic variants associated with melanoma risk or naevus count in wild-type MC1R melanoma patients
Authors:Reference: British Journal Of Dermatology 2022. -
Dermatoscopic and clinical features of congenital or congenital-type nail matrix nevi: A multicenter prospective cohort study by the International Dermoscopy Society
Authors:Reference: Journal Of The American Academy Of Dermatology 2022. -
Validation of artificial intelligence prediction models for skin cancer diagnosis using dermoscopy images: the 2019 International Skin Imaging Collaboration Grand Challenge
Authors:Reference: Lancet Digital Health, The 2022. -
Cross-cohort gut microbiome associations with immune checkpoint inhibitor response in advanced melanoma
Authors:Reference: Nature Medicine 2022. -
Using a 31-Gene Expression Profile Test to Stratify Patients with Stage I-II Cutaneous Melanoma According to Recurrence Risk: Update to a Prospective, Multicenter Study
Authors:Reference: Cancers 2022.
Featured Projects
-
Medicina personalizada en melanoma: biomarcadores de pronóstico y respuesta a inmunoterapia, y su relación con la dieta y ejercicio físico
Principal investigator: Susana PuigFunder: Instituto de Salud Carlos IIICode: PI22/01457Duration: 01/01/2023 - 31/12/2025 -
MELCAYA - Novel health care strategies for melanoma in children, adolescents and young adults
Principal investigator: Susana Puig SardaFunder: European CommissionCode: CE_HE_CANCER21_RIADuration: 01/12/2022 - 30/11/2026 -
Monitoring multidimensional aspects of QUAlity of Life after cancer ImmunoTherapy - an Open smart digital Platform for personalized prevention and patient management.
Principal investigator: Susana Puig SardaFunder: European CommissionCode: CE_H2020-SC1_19_1s24Duration: 01/01/2020 - 30/06/2024 -
Implicación del perfil inmunológico específico cutáneo determinado en sangre periférica en el pronóstico y respuesta a tratamiento del melanoma
Principal investigator: Susana Puig SardaFunder: Instituto de Salud Carlos IIICode: PI18/00419Duration: 02/01/2019 - 31/12/2021 -
Vías de diseminación mestastásica en distintos subtipos del melanoma maligno: nuevos biomarcadores tumorales y dianas terapeuticas
Principal investigator: Josep Malvehy GuileraFunder: Asociación Española Contra el CáncerCode: GCB15152978SOENDuration: 01/07/2015 - 31/12/2020